Collection's Items (Sorted by Year in Descending order): 1 to 20 of 2282
| Preview | Issue Date | Title | Author(s) |
| 2024 | De novo AA amyloidosis in a transplant kidney | Duxbury, Hayley; Bayly, Angela; Nankivell, Brian J.; Kwok, Fiona S. M.; Li, Jennifer S.; Shingde, Meena; Duxbury, Hayley; Bayly, Angela; Nankivell, Brian J.; Kwok, Fiona S. M.; Li, Jennifer S.; Shingde, Meena | |
| 2024 | Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma | Kennedy, O. J.; Glassee, N.; Kicinski, M.; Blank, C. U.; Long, G. V.; Atkinson, V. G.; Dalle, S.; Haydon, A. M.; Meshcheryakov, A.; Khattak, A.; Carlino, Matteo S.; Sandhu, S.; Larkin, J.; Puig, S.; Ascierto, P. A.; Rutkowski, P.; Schadendorf, D.; Boers-Sonderen, M.; Giacomo, A. M. D.; van den Eertwegh, A. J. M.; Grob, J. J.; Gutzmer, R.; Jamal, R.; van Akkooi, A. C. J.; Gandini, S.; Buhrer, E.; Suciu, S.; Robert, C.; Eggermont, A. M. M.; Mandala, M.; Lorigan, P.; Valpione, S.; Carlino, Matteo S. | |
| 2024 | Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study | Mandala, M.; Lorigan, P.; Sergi, M. C.; Benannoune, N.; Serra, P.; Vitale, M. G.; Giannarelli, D.; Arance, A. M.; Couselo, E. M.; Neyns, B.; Tucci, M.; Guida, M.; Spagnolo, F.; Rossi, E.; Occelli, M.; Queirolo, P.; Quaglino, P.; Depenni, R.; Merelli, B.; Placzke, J.; Di Giacomo, A. M.; Del Vecchio, M.; Indini, A.; da Silva, Ines Pires; Menzies, A. M.; Long, G. V.; Robert, C.; Rutkowski, P.; Ascierto, P. A.; da Silva, Ines Pires | |
| 2024 | Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy | Taylor, A. M.; McKeown, J.; Dimitriou, F.; Jacques, Sarah; Zimmer, L.; Allayous, C.; Yeoh, H. L.; Haydon, A.; Ressler, J. M.; Galea, C.; Woodford, R.; Kahler, K.; Hauschild, A.; Festino, L.; Hoeller, C.; Schwarze, J. K.; Neyns, B.; Wicky, A.; Michielin, O.; Placzke, J.; Rutkowski, P.; Johnson, D. B.; Lebbe, C.; Dummer, R.; Ascierto, P. A.; Lo, S.; Long, G. V.; Carlino, Matteo S.; Menzies, A. M.; Jacques, Sarah; Carlino, Matteo S. | |
| 2024 | Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort | Tang, L. J.; Sun, D. Q.; Song, S. J.; Yip, T. C. F.; Wong, G. L. H.; Zhu, P. W.; Chen, S. D.; Karsdal, M.; Leeming, D. J.; Jiang, P.; Wang, C.; Chen, Q.; Byrne, C. D.; Targher, G.; Eslam, Mohammed; George, Jacob; Wong, V. W. S.; Zheng, M. H.; Eslam, Mohammed; George, Jacob | |
| 2024 | Time to broaden the screening strategy for chronic hepatitis B virus infection beyond the emergency department. | Kalo, Eric; Baig, Asma; Read, Scott A.; Ahlenstiel, Golo; Kalo, Eric; Baig, Asma; Read, Scott A.; Ahlenstiel, Golo | |
| 2024 | Localised gastric amyloidosis presenting as a bleeding ulcerated mass lesion - a case study | Seif, Jonathan; Viswanathan, Seethalakshmi; Seif, Jonathan; Viswanathan, Seethalakshmi | |
| 2024 | A systematic review and narrative analysis of the evidence for individual psychodynamically informed psychotherapy in the treatment of dissociative identity disorder in adults | Yeates, Steven; Korner, Anthony J.; McLean, Loyola; Yeates, Steven; Korner, Anthony J.; McLean, Loyola | |
| 2024 | Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy | Jacques, Sarah; McKeown, J.; Grover, P.; Johnson, D. B.; Zaremba, A.; Dimitriou, F.; Weiser, R.; Farid, M.; Namikawa, K.; Sullivan, R. J.; Rutkowski, P.; Lebbe, C.; Hamid, O.; Zager, J. S.; Michielin, O.; Neyns, B.; Nakamura, Y.; Robert, C.; Mehnert, J.; Ascierto, P. A.; Bhave, P.; Park, B.; Zimmer, L.; Mangana, J.; Mooradian, M.; Placzke, J.; Allayous, C.; Glitza Oliva, I. C.; Mehmi, I.; Depalo, D.; Wicky, A.; Schwarze, J. K.; Roy, S.; Boatwright, C.; Vanella, V.; Long, G. V.; Menzies, A. M.; Lo, S. N.; Carlino, Matteo S.; Jacques, Sarah; Carlino, Matteo S. | |
| 2024 | Cardiac inflammation in populations with systemic sclerosis evaluated by T1 mapping via magnetic resonance: A systematic review and Meta Analysis | Khanna, Shaun; Li, Cindy; Leung, Alice N. W.; Amarasekera, Anjalee T.; Bhat, Aditya; Chen, Henry H.; Gan, Gary C. H.; Tan, Timothy C.; Khanna, Shaun; Li, Cindy; Leung, Alice N. W.; Amarasekera, Anjalee T.; Bhat, Aditya; Chen, Henry H.; Gan, Gary C. H.; Tan, Timothy C. | |
| 2024 | Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study | Shaikh, F.; Wynne, R.; Castelino, Ronald L.; Inglis, S. C.; Davidson, P. M.; Ferguson, Caleb; Castelino, Ronald L.; Ferguson, Caleb | |
| 2024 | Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trial | Russell, M.; Emmett, L.; Peric, B.; Saw, R.; Spillane, J.; Vazquez, V.; Duprat, J.; Moncreiff, M.; Allan, C.; Leeuwen, B. V.; Pritchard-Jones, R.; Rastrelli, M.; de Wilt, H.; Geh, J.; Howle, Julie R.; Spillane, A.; Howle, Julie R. | |
| 2024 | Use of anticoagulation for thromboembolic prophylaxis in patients with atrial high-rate episodes on device monitoring: A narrative review | Leung, Alice N. W.; Bhat, Aditya; Leung, Alice N. W.; Bhat, Aditya | |
| 2024 | First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142 | Lenz, H. J.; Overman, M. J.; Van Cutsem, E.; Limon, M. L.; Wong, Mark; Hendlisz, A.; Aglietta, M.; Garcia-Alfonso, P.; Neyns, B.; Gelsomino, F.; Cardin, D. B.; Dragovich, T.; Shah, U.; McCraith, S.; Wang, R.; Lei, M.; Yao, J.; Jin, L.; Lonardi, S.; Wong, Mark | |
| 2024 | Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT) | Fantoni, A.; Warburton, L.; Solomon, B.; Alexander, M.; Maddula, Meghana; Brown, Lauren J.; da Silva, Ines P.; Nagrial, Adnan M.; Abu Al-Hial, F.; Itchins, M.; Pavlakis, N.; Bowyer, S.; Maddula, Meghana; Brown, Lauren J.; da Silva, Ines P.; Nagrial, Adnan M. | |
| 2024 | Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long- term outcomes from the JAVELIN Bladder 100 trial in patients (pts) with high body mass index (BMI) | Aragon-Ching, J. B.; Petrylak, D. P.; Sridhar, Srikala S.; Gupta, S.; Grivas, P.; Powles, T.; Gurney, Howard; Jacob, N.; Tyroller, K.; Guenther, S.; Bellmunt, J.; Sridhar, Srikala S.; Gurney, Howard | |
| 2024 | Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study | McLean, L. S.; Lim, A. M.; Bressel, M.; Lee, J.; Ladwa, R.; Guminski, A. D.; Hughes, B.; Bowyer, S.; Briscoe, K.; Harris, S.; Kukard, C.; Zielinski, R.; Alamgeer, M.; Carlino, M.; Mo, Jeremy; Park, J. J.; Khattak, M. A.; Day, F.; Rischin, D.; Carlino, Matteo S.; Mo, Jeremy | |
| 2024 | A classic and an unusual presentation of atheroembolic renal disease | Teo, Kai Z.; Tarafdar, Surjit; Cheng, J.; Bayly, Angela; Viswanathan, Seethalakshmi; Teo, Kai Z.; Tarafdar, Surjit; Bayly, Angela; Viswanathan, Seethalakshmi | |
| 2024 | Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy | Rogiers, A.; Dimitriou, F.; Lobon, I.; Harvey, C.; Vergara, I. A.; Pires da Silva, Ines; Lo, S. N.; Scolyer, Richard A.; Carlino, Matteo S.; Menzies, A. M.; Long, G. V.; Pires da Silva, Ines; Carlino, Matteo S. | |
| 2024 | SAFFRON-103: a phase Ib study of sitravatinib plus tislelizumab in anti-PD-(L)1 refractory/resistant advanced melanoma | Wang, X.; Pan, H.; Cui, J.; Chen, X.; Yoon, Won-Hee; Carlino, Matteo S.; Li, X.; Li, H.; Zhang, J.; Sun, J.; Guo, J.; .; Yoon, Won-Hee; Carlino, Matteo S. | |
Collection's Items (Sorted by Year in Descending order): 1 to 20 of 2282
